Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Operating expenses:
Research and development	$ 144,101	$ 114,243
General and administrative	48,849	49,919
Total operating expenses	192,950	164,162
Loss from operations	(192,950)	(164,162)
Interest income and other, net	25,490	29,224
Loss before income taxes	(167,460)	(134,938)
Income tax expense	(925)	(1,018)
Net loss	(168,385)	(135,956)
Other comprehensive income
Unrealized gain on available-for-sale investments	26	891
Comprehensive loss	$ (168,359)	$ (135,065)
Net loss per share - basic and diluted
Net loss per share - basic	$ (2.00)	$ (1.63)
Net loss per share - diluted	$ (2.00)	$ (1.63)
Weighted-average number of common shares - basic and diluted
Weighted-average number of common shares - basic	84,264,715	83,389,750
Weighted-average number of common shares - diluted	84,264,715	83,389,750